₹94.95
−5.90%NSE close, 16 Nov 2026
−18.25%
Themis Medicare is a small cap company, listed on NSE under the symbol THEMISMED. At ₹94.95 a share, the market values the whole company at ₹874 crore.
In FY26, it reported sales of ₹342 crore and a net profit of ₹1 crore, an operating margin of 0.1%. Over the last three years, sales fell 1.1% a year and net profit fell 72.8% a year.
The market values the company at 17.3 times its profit over the last twelve months and 2.06 times its book value; its return on equity is 11.9% and its borrowings are 0.18 times its equity.
Promoters hold 67.11% of the shares, and have pledged 45.8% of their holding. Foreign institutions hold 0.01%, and domestic institutions, mutual funds among them, 0.01%.
Over the past year the share price has fallen 19.7%, and it is 32.5% below its 52-week high.
₹ crore. Consolidated figures.
The un-audited standalone & consolidated financial results for the quarter and half year ended September 30, 2026.
Postal Ballot Notice
A copy Scrutinizer's Report of 56th Annual General Meeting (AGM) counter signed by the Chairman of the Company. Further, the Company has informed the Exchange regarding voting results of 56th AGM.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 82.5 | 97.8 | 123 | 117 | 93.8 | 71.7 | 97.6 | 78.0 | 90.1 | 76.5 | 87.0 | 89.7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 74.5 | 88.5 | 93.8 | 99.9 | 85.3 | 77.5 | 108 | 81.1 | 80.3 | 72.8 | 139 | 84.2 |
| Operating profit | 8.1 | 9.3 | 29.2 | 17.1 | 8.5 | −5.8 | −10.1 | −3.1 | 9.8 | 3.8 | −52.4 | 5.6 |
| Operating margin | 9.8% | 9.5% | 23.7% | 14.6% | 9.1% | -8.1% | -10.3% | -4.0% | 10.9% | 4.9% | -60.3% | 6.2% |
| Other income | 0.6 | 1.1 | 1.0 | 1.1 | 1.0 | 1.6 | 1.2 | 3.2 | 1.3 | 3.7 | 1.0 | 4.1 |
| Interest | 2.7 | 2.2 | 2.4 | 2.4 | 2.8 | 2.5 | 2.5 | 2.8 | 2.8 | 2.7 | 3.0 | 2.1 |
| Depreciation | 3.1 | 3.1 | 2.4 | 2.5 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.6 | 2.5 | 2.6 |
| Profit before tax | 2.9 | 5.2 | 25.4 | 13.4 | 4.2 | −9.2 | −13.9 | −5.2 | 4.9 | 2.1 | 36.0 | 5.1 |
| Tax | 0.9 | 2.1 | 6.7 | 3.5 | 1.1 | −1.5 | 0.2 | 0.2 | 0.3 | 0.2 | 14.0 | 1.2 |
| Net profit | 7.4 | 6.6 | 24.7 | 14.3 | 0.5 | −9.7 | −14.3 | −3.6 | 10.1 | 8.9 | 24.6 | 7.1 |
| EPS (₹) | 0.80 | 0.72 | 2.68 | 1.55 | 0.06 | -1.05 | -1.54 | -0.39 | 1.10 | 0.96 | 2.67 | 0.77 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 184 | 202 | 231 | 395 | 354 | 382 | 406 | 342 |
| Expenses | 181 | 166 | 181 | 299 | 287 | 330 | 356 | 342 |
| Operating profit | 2.3 | 35.7 | 49.5 | 95.6 | 67.5 | 51.5 | 49.1 | 0.4 |
| Operating margin | 1.2% | 17.7% | 21.5% | 24.2% | 19.0% | 13.5% | 12.1% | 0.1% |
| Other income | 2.7 | 3.5 | 3.6 | 6.5 | 11.5 | 4.8 | 4.7 | 9.4 |
| Interest | 11.8 | 12.9 | 12.7 | 8.8 | 9.6 | 9.4 | 10.0 | 10.7 |
| Depreciation | 8.0 | 8.3 | 8.6 | 9.5 | 10.5 | 12.3 | 9.9 | 10.3 |
| Profit before tax | −14.9 | 18.0 | 31.9 | 83.9 | 58.9 | 34.7 | 33.8 | −12.1 |
| Tax | −1.8 | 2.1 | 5.6 | 22.4 | 15.6 | 9.9 | 9.8 | 0.8 |
| Net profit | −10.7 | 24.8 | 35.7 | 72.9 | 56.8 | 43.5 | 29.8 | 1.1 |
| EPS (₹) | -11.72 | 26.97 | 38.86 | 79.22 | 61.85 | 33.59 | 3.24 | 0.12 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 34.4 | 34.7 | −3.3 | −57.4 |
| From investing | −15.2 | −12.2 | −2.5 | 99.8 |
| From financing | −17.6 | −25.9 | 3.8 | −30.9 |
| Spent on fixed assets | −20.3 | −15.4 | −4.9 | −2.0 |
| Free cash flow | 14.1 | 19.3 | −8.1 | −59.4 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | -5.8% | 12.3% | 15.5% | 18.5% | 16.0% | 11.4% | 7.4% | 0.3% |
| Operating margin | 1.2% | 17.7% | 21.5% | 24.2% | 19.0% | 13.5% | 12.1% | 0.1% |
| Return on equity | – | – | – | – | 16.7% | 11.5% | 7.4% | 0.3% |
| Return on capital employed | – | – | – | – | 15.9% | 9.3% | 9.0% | -0.3% |
| Return on assets | – | – | – | – | 11.1% | 7.7% | 5.1% | 0.2% |
| Debt to equity | – | – | – | – | 0.27 | 0.25 | 0.21 | 0.25 |
| Interest coverage | -0.30 | 2.40 | 3.50 | 10.60 | 7.20 | 4.70 | 4.40 | -0.10 |
| Debt to assets | – | – | – | – | 0.18 | 0.17 | 0.14 | 0.17 |
| Current ratio | – | – | – | – | 1.90 | 1.90 | 1.95 | 1.84 |
| Quick ratio | – | – | – | – | 1.41 | 1.44 | 1.41 | 1.35 |
| Cash ratio | – | – | – | – | 0.09 | 0.06 | 0.04 | 0.03 |
| Asset turnover | – | – | – | – | 0.69 | 0.67 | 0.69 | 0.57 |
| Fixed asset turnover | – | – | – | – | 2.20 | 2.27 | 2.36 | 2.06 |
| Inventory turnover | – | – | – | – | – | 1.90 | 1.60 | 1.60 |
| Receivables turnover | – | – | – | – | 2.40 | 2.10 | 2.30 | 1.90 |
| Gross margin | – | – | – | – | – | 64.2% | 67.5% | 62.2% |
| Cash from operations to profit | – | – | – | 47.0% | – | – | 116.0% | -287.0% |
| Effective tax rate | – | 11.6% | 17.7% | 26.7% | 26.5% | 28.6% | 29.2% | – |
Scrutinizer's Report and voting results of Annual General Meeting held on September 30, 2026
The Amendment to AOA/MOA of the company.
The Amendment to AOA/MOA of the company.
Proceedings of Annual General Meeting held on September 30, 2025
The Withdrawal of proposed Preferential Issue of 45,95,795 convertible equity warrants.
General Updates of Record Date for the Dividend for FY 2025-26.
Notice of 56th Annual General Meeting to be held on September 30, 2026
Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to…